Skip to main content

Facebook LIVE Q&A: Alzheimer’s disease, clinical trials, and COVID-19

May 1, 2020 @ 11:00 AM – 11:30 AM
Kirsten Klein

How to Attend Live & Ask Questions:

  1. Login (or create an account) at
  2. Click this DIRECT LINK or visit our Facebook page (@UCIrvineMIND) on Friday at 11 AM  (You can also “Like” and “Follow” our page in advance to receive notifications when we go live).
  3. Scroll down our page to find the video, watch it live, and type questions into the comments box.

About the Speaker:

Daniel Gillen received his PhD in Biostatistics from the University of Washington and leads the Data Management and Statistics Core for UCI MIND’s NIH-designated Alzheimer’s Disease Research Center. He is an elected fellow of the American Statistical Association and widely recognized for his work in the design and analysis of clinical trials for Alzheimer’s disease and other health conditions. Dr. Gillen serves on numerous Data Safety and Monitoring Boards, evaluating the safety of ongoing clinical trials nationally and internationally, and he has participated on multiple FDA advisory panels that are instrumental in deciding which drugs get approved and which do not.